Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hereditary Breast and Ovarian Cancer Syndrome clinical trials
1 of 3 indexed Hereditary Breast and Ovarian Cancer Syndrome trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Hereditary Breast and Ovarian Cancer Syndrome: 3 US clinical trials tracked, 1 recruiting.
Hereditary Breast and Ovarian Cancer Syndrome is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Georgetown University, running 2 of these trials.
Enrollment posture brief
Registry condition hereditary-breast-and-ovarian-cancer-syndrome
OPEN 1 | RECR 33% | LATE 0 | EARLY 0 | RANK #5209 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Hereditary Breast and Ovarian Cancer Syndrome lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hereditary Breast and Ovarian Cancer Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hereditary Breast and Ovarian Cancer Syndrome is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
Georgetown University
NCT06892275
Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention
M.D. Anderson Cancer Center
NCT05677048
Enhance the Use of Genetic Counseling and Testing in Latinas
Georgetown University
NCT04544501
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Hereditary Breast and Ovarian Cancer Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hereditary Breast and Ovarian Cancer Syndrome trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hereditary Breast and Ovarian Cancer Syndrome page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Hereditary Breast and Ovarian Cancer Syndrome trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Georgetown University sponsors the most Hereditary Breast and Ovarian Cancer Syndrome trials on record, review their full trial history before evaluating a specific study. See Georgetown University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hereditary Breast and Ovarian Cancer Syndrome condition card totals 3 registered trials; most-linked intervention FORCE Fact Sheet; top US site state District of Columbia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.